Literature DB >> 24412279

Manipulation of cellular DNA damage repair machinery facilitates propagation of human papillomaviruses.

Nicholas A Wallace1, Denise A Galloway2.   

Abstract

In general, the interplay among viruses and DNA damage repair (DDR) pathways can be divided based on whether the interaction promotes or inhibits the viral lifecycle. The propagation of human papillomaviruses is both promoted and inhibited by DDR proteins. As a result, HPV proteins both activate repair pathways, such as the ATM and ATR pathways, and inhibit other pathways, most notably the p53 signaling pathway. Indeed, the role of HPV proteins, with regard to the DDR pathways, can be divided into two broad categories. The first set of viral proteins, HPV E1 and E2 activate a DNA damage response and recruit repair proteins to viral replication centers, where these proteins are likely usurped to replicate the viral genome. Because the activation of the DDR response typically elicits a cell cycle arrest that would impeded the viral lifecycle, the second set of HPV proteins, HPV E6 and E7, prevents the DDR response from pausing cell cycle progression or inducing apoptosis. This review provides a detailed account of the interactions among HPV proteins and DDR proteins that facilitate HPV propagation.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  DNA damage repair; HPV; HPV replication

Mesh:

Substances:

Year:  2014        PMID: 24412279      PMCID: PMC4050178          DOI: 10.1016/j.semcancer.2013.12.003

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  197 in total

1.  Post-transcriptional induction of p21cip1 protein by human papillomavirus E7 inhibits unscheduled DNA synthesis reactivated in differentiated keratinocytes.

Authors:  Y Jian; D C Schmidt-Grimminger; W M Chien; X Wu; T R Broker; L T Chow
Journal:  Oncogene       Date:  1998-10-22       Impact factor: 9.867

2.  DNA damage activates p53 through a phosphorylation-acetylation cascade.

Authors:  K Sakaguchi; J E Herrera; S Saito; T Miki; M Bustin; A Vassilev; C W Anderson; E Appella
Journal:  Genes Dev       Date:  1998-09-15       Impact factor: 11.361

3.  The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes.

Authors:  K Münger; W C Phelps; V Bubb; P M Howley; R Schlegel
Journal:  J Virol       Date:  1989-10       Impact factor: 5.103

4.  Enhanced phosphorylation of p53 by ATM in response to DNA damage.

Authors:  S Banin; L Moyal; S Shieh; Y Taya; C W Anderson; L Chessa; N I Smorodinsky; C Prives; Y Reiss; Y Shiloh; Y Ziv
Journal:  Science       Date:  1998-09-11       Impact factor: 47.728

5.  Adeno-associated virus Rep78 protein interacts with protein kinase A and its homolog PRKX and inhibits CREB-dependent transcriptional activation.

Authors:  G Di Pasquale; S N Stacey
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

6.  The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53.

Authors:  M Scheffner; B A Werness; J M Huibregtse; A J Levine; P M Howley
Journal:  Cell       Date:  1990-12-21       Impact factor: 41.582

7.  The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product.

Authors:  N Dyson; P M Howley; K Münger; E Harlow
Journal:  Science       Date:  1989-02-17       Impact factor: 47.728

8.  The E7 proteins of the nononcogenic human papillomavirus type 6b (HPV-6b) and of the oncogenic HPV-16 differ in retinoblastoma protein binding and other properties.

Authors:  J R Gage; C Meyers; F O Wettstein
Journal:  J Virol       Date:  1990-02       Impact factor: 5.103

9.  The E7 protein of human papillomavirus type 16 sensitizes primary human keratinocytes to apoptosis.

Authors:  H Stöppler; M C Stöppler; E Johnson; C M Simbulan-Rosenthal; M E Smulson; S Iyer; D S Rosenthal; R Schlegel
Journal:  Oncogene       Date:  1998-09-10       Impact factor: 9.867

10.  Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product.

Authors:  K Münger; B A Werness; N Dyson; W C Phelps; E Harlow; P M Howley
Journal:  EMBO J       Date:  1989-12-20       Impact factor: 11.598

View more
  35 in total

1.  Pharmacologic inhibition of ATR and ATM offers clinically important distinctions to enhancing platinum or radiation response in ovarian, endometrial, and cervical cancer cells.

Authors:  Pang-ning Teng; Nicholas W Bateman; Kathleen M Darcy; Chad A Hamilton; George Larry Maxwell; Christopher J Bakkenist; Thomas P Conrads
Journal:  Gynecol Oncol       Date:  2015-01-02       Impact factor: 5.482

Review 2.  DNA damage response is hijacked by human papillomaviruses to complete their life cycle.

Authors:  Shi-Yuan Hong
Journal:  J Zhejiang Univ Sci B       Date:  2017 Mar.       Impact factor: 3.066

3.  TP53 Arg72Pro polymorphism is associated with increased overall survival but not response to therapy in Portuguese/Caucasian patients with advanced cervical cancer.

Authors:  Ana Coelho; Augusto Nogueira; Sílvia Soares; Joana Assis; Deolinda Pereira; Isabel Bravo; Raquel Catarino; Rui Medeiros
Journal:  Oncol Lett       Date:  2018-03-26       Impact factor: 2.967

4.  Differential expression profile analysis of DNA damage repair genes in CD133+/CD133- colorectal cancer cells.

Authors:  Yuhong Lu; Xin Zhou; Qingliang Zeng; Daishun Liu; Changwu Yue
Journal:  Oncol Lett       Date:  2017-06-19       Impact factor: 2.967

5.  ATR inhibition sensitizes HPV- and HPV+ head and neck squamous cell carcinoma to cisplatin.

Authors:  Brandon C Leonard; Eliot D Lee; Neil E Bhola; Hua Li; Kristian K Sogaard; Christopher J Bakkenist; Jennifer R Grandis; Daniel E Johnson
Journal:  Oral Oncol       Date:  2019-06-06       Impact factor: 5.337

6.  p38MAPK and MK2 pathways are important for the differentiation-dependent human papillomavirus life cycle.

Authors:  Ayano Satsuka; Kavi Mehta; Laimonis Laimins
Journal:  J Virol       Date:  2014-11-19       Impact factor: 5.103

7.  Dysregulation of hsa-miR-34a and hsa-miR-449a leads to overexpression of PACS-1 and loss of DNA damage response (DDR) in cervical cancer.

Authors:  Mysore S Veena; Santanu Raychaudhuri; Saroj K Basak; Natarajan Venkatesan; Parameet Kumar; Roopa Biswas; Rita Chakrabarti; Jing Lu; Trent Su; Marcus Gallagher-Jones; Marco Morselli; Haiqing Fu; Matteo Pellegrini; Theodore Goldstein; Mirit I Aladjem; Matthew B Rettig; Sharon P Wilczynski; Daniel Sanghoon Shin; Eri S Srivatsan
Journal:  J Biol Chem       Date:  2020-10-07       Impact factor: 5.157

8.  Suppression of MicroRNA 424 Levels by Human Papillomaviruses Is Necessary for Differentiation-Dependent Genome Amplification.

Authors:  Shiyuan Hong; Shouqiang Cheng; William Songock; Jason Bodily; Laimonis A Laimins
Journal:  J Virol       Date:  2017-11-30       Impact factor: 5.103

Review 9.  What's the damage? The impact of pathogens on pathways that maintain host genome integrity.

Authors:  Matthew D Weitzman; Jonathan B Weitzman
Journal:  Cell Host Microbe       Date:  2014-03-12       Impact factor: 21.023

10.  The mutational landscape of recurrent versus nonrecurrent human papillomavirus-related oropharyngeal cancer.

Authors:  R Alex Harbison; Mark Kubik; Eric Q Konnick; Qing Zhang; Seok-Geun Lee; Heuijoon Park; Jianan Zhang; Christopher S Carlson; Chu Chen; Stephen M Schwartz; Cristina P Rodriguez; Umamaheswar Duvvuri; Eduardo Méndez
Journal:  JCI Insight       Date:  2018-07-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.